Oncology
The ageing of the population and increasing exposure to carcinogens are the main reasons for the expanding patient population. These developments are leading the way towards new technologies, drugs and targets that will change the treatment options for all types of cancer. A dedicated session will focus on emerging technologies, public-private partnerships and commercialisation strategies.
Enabling technologies and services that drive the industry
New developments in enabling technologies such as bio-informatics, medical devices, novel gene technologies and innovative drug delivery systems are reshaping the market and play a major role in the future development of the Life Sciences sector. What implications do these revolutionary innovations have for the development of new medicines?
Cardiovascular diseases
Cardiovascular diseases represent the predominant cause of death and morbidity in Western cultures. New (enabling) technologies such as genomics, imaging and biomarkers offer new possibilities for the prediction, early diagnosis and treatment of cardiovascular diseases. In this session industry leaders and key researchers will focus on these trends and developments.
Infectious diseases
Both emerging and existing infectious diseases pose a major threat to public health, in both the developed and the developing worlds. Increased antibiotic resistance and the rapid spread of new viruses have hastened the need for new antiviral and antibacterial agents and (manufacturing) technologies. This session will address emerging technologies and business development strategies.
and furthermore...
Business Opportunities
The congress provides an opportunity for companies to pitch for funds, with investors being provided with information to make informed investment decisions in the investors forum. In addition, Dutch research institutions and academic centres will present an overview of business cases for entrepreneurs who wish to start their own Life Sciences company. Finally, licensing opportunities are on offer for companies that wish to boost their R&D with innovative ideas and technologies with market potential.
|
